Unibest
← Back to patent-cliff list

Fultagliptin Benzoate

Tier C — Watch / trade

Fultagliptin Benzoate

-
Originator
2024
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type

Targets:DPP4

Indications (approved):Type 2 diabetes

Regional status

US
-
EU
-
China
Approved
2024-06-28
Japan
-

Factories producing this API4

Factories registered as producing this API in our sourcing network (RFQ records + product master), sorted by RFQ activity; the snapshot carries no cost or customer data.

4 producing factories on file — sign in to view the named list (factory details are not shown to guests).

Sign in to view factories →

Synthetic routes & intermediates1 routes

Originator routes × 1Optimised (non-patent) × 0Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 9 · Total yield 42.4 g
FOTAG-001112399-50-5FOTAG-0021312954-50-9FOTAG-0031312954-51-0FOTAG-0041312954-52-1FOTAG-0051312954-53-2FOTAG-0061312954-54-3FOTAG-007309956-78-3FOTAG-0081312954-55-4FOTAG-0091312954-57-6Fotagliptin—Fotagliptin Benzoate1403496-40-1API · Fultagliptin Benzoate
CodeCAS No.Intermediate
FOTAG-001112399-50-51-bromo-2-(bromomethyl)-4-fluorobenzene
FOTAG-0021312954-50-91-bromo-4-fluoro-2-(isothiocyanatomethyl)benzene
FOTAG-0031312954-51-0N-(2-bromo-5-fluorobenzyl)hydrazinecarbothioamide
FOTAG-0041312954-52-1(Z)-methyl 2-(2-((2-bromo-5-fluorobenzyl)carbamothioyl)hydrazono)propanoate
FOTAG-0051312954-53-24-(2-bromo-5-fluorobenzyl)-6-methyl-3-thioxo-3,4-dihydro-1,2,4-triazin-5(2H)-one
FOTAG-0061312954-54-34-(2-bromo-5-fluorobenzyl)-6-methyl-3-(methylthio)-1,2,4-triazin-5(4H)-one
FOTAG-007309956-78-3Available(R)-tert-butyl piperidin-3-ylcarbamate
FOTAG-0081312954-55-4(R)-tert-butyl (1-(4-(2-bromo-5-fluorobenzyl)-6-methyl-5-oxo-4,5-dihydro-1,2,4-triazin-3-yl)piperidin-3-yl)carbamate
FOTAG-0091312954-57-6(R)-tert-butyl (1-(4-(2-cyano-5-fluorobenzyl)-6-methyl-5-oxo-4,5-dihydro-1,2,4-triazin-3-yl)piperidin-3-yl)carbamate
Fotagliptin-(R)-2-((3-(3-aminopiperidin-1-yl)-6-methyl-5-oxo-1,2,4-triazin-4(5H)-yl)methyl)-4-fluorobenzonitrile
Fotagliptin Benzoate1403496-40-1-

Frequently asked questions

What are the approved indications of Fultagliptin Benzoate?

Approved indications include: Type 2 diabetes.

When does the Fultagliptin Benzoate patent expire?

No public expiry year is available for Fultagliptin Benzoate yet; this page updates once verified.

How many synthesis routes are recorded for Fultagliptin Benzoate?

1 synthesis routes are recorded; the shortest is 9 steps with 42.4 g total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Fultagliptin Benzoate intermediates?

1 intermediate CAS of Fultagliptin Benzoate are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.

How do I get a quote for Fultagliptin Benzoate intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-29